Better Therapeutics Stock Shares Outstanding
Better Therapeutics fundamentals help investors to digest information that contributes to Better Therapeutics' financial success or failures. It also enables traders to predict the movement of Better OTC Stock. The fundamental analysis module provides a way to measure Better Therapeutics' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Better Therapeutics otc stock.
Better |
Better Therapeutics OTC Stock Shares Outstanding Analysis
Better Therapeutics' Outstanding Shares are shares of common stock of a public company that were purchased by investors after they were authorized and issued by the company to the public. Outstanding Shares are typically reported on fully diluted basis, including exotic instruments such as options, or convertibles bonds.
Current Better Therapeutics Shares Outstanding | 54.52 M |
Most of Better Therapeutics' fundamental indicators, such as Shares Outstanding, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Better Therapeutics is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Outstanding shares that are stated on company Balance Sheet are used when calculating many important valuation and performance indicators including Return on Equity, Market Cap, EPS and many others.
CompetitionBased on the latest financial disclosure, Better Therapeutics has 54.52 M of shares currently outstending. This is 69.8% lower than that of the Biotechnology sector and 48.98% lower than that of the Health Care industry. The shares outstanding for all United States stocks is 90.47% higher than that of the company.
Better Shares Outstanding Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Better Therapeutics' direct or indirect competition against its Shares Outstanding to detect undervalued stocks with similar characteristics or determine the otc stocks which would be a good addition to a portfolio. Peer analysis of Better Therapeutics could also be used in its relative valuation, which is a method of valuing Better Therapeutics by comparing valuation metrics of similar companies.Better Therapeutics is currently under evaluation in shares outstanding category among its peers.
Better Fundamentals
| Return On Equity | -10.22 | |||
| Return On Asset | -0.95 | |||
| Current Valuation | 8.83 M | |||
| Shares Outstanding | 54.52 M | |||
| Shares Owned By Insiders | 53.41 % | |||
| Shares Owned By Institutions | 2.94 % | |||
| Number Of Shares Shorted | 2.13 M | |||
| Price To Book | 2.29 X | |||
| Price To Sales | 49,559 X | |||
| Gross Profit | (674 K) | |||
| EBITDA | (29.18 M) | |||
| Net Income | (31.57 M) | |||
| Cash And Equivalents | 29.68 M | |||
| Cash Per Share | 1.25 X | |||
| Total Debt | 14.88 M | |||
| Debt To Equity | 0.81 % | |||
| Current Ratio | 5.23 X | |||
| Book Value Per Share | (0.24) X | |||
| Cash Flow From Operations | (26.08 M) | |||
| Short Ratio | 0.94 X | |||
| Earnings Per Share | (1.10) X | |||
| Target Price | 5.25 | |||
| Number Of Employees | 54 | |||
| Beta | 2.35 | |||
| Market Capitalization | 1.12 M | |||
| Total Asset | 22.94 M | |||
| Retained Earnings | (111.5 M) | |||
| Working Capital | 4.95 M | |||
| Z Score | -10.7 | |||
| Net Asset | 22.94 M |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any otc stock could be closely tied with the direction of predictive economic indicators such as signals in estimate. You can also try the Technical Analysis module to check basic technical indicators and analysis based on most latest market data.
Other Consideration for investing in Better OTC Stock
If you are still planning to invest in Better Therapeutics check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Better Therapeutics' history and understand the potential risks before investing.
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
| Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device |